BELLICUM PHARMACEUTICALS, INC 4
4 · BELLICUM PHARMACEUTICALS, INC · Filed May 26, 2017
Insider Transaction Report
Form 4
Musso Alan A
CFO and Treasurer
Transactions
- Sale
Common Stock
2017-05-25$12.24/sh−6,311$77,254→ 54,908 total
Footnotes (2)
- [F1]Represents shares sold to satisfy tax liabilities and withholding obligations in connection with vesting of 14,706 shares of common stock from the Restricted Stock Awards granted to the Reporting Person on December 17, 2014.
- [F2]Includes 671 shares acquired under the Issuer's Employee Stock Purchase Plan on December 9, 2016.